Assenagon Asset Management
AMAG

Assenagon Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Assenagon Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-208,261
Closed -$1.96M – 1340
2020
Q3 		$1.96M Sell
208,261
-134,494
-39% -$1.28M 0.01% 597
2020
Q2 		$2.62M Buy
+342,755
New +$2.62M 0.02% 516

Assenagon Asset Management's AMAG Position: Q4 2020 in Review

Assenagon Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 208,261 shares — an estimated $1.96M sold.

Assenagon Asset Management first reported a position in AMAG in Q2 2020 and held it in 2 quarters. The position peaked at $2.62M in Q2 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Assenagon Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 208,261 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.96M.
  • Assenagon Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Assenagon Asset Management's AMAG Pharmaceuticals position peaked at $2.62M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Assenagon Asset Management's 13F filing for Q4 2020, filed 1 Feb 2021.